Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

A collateral circulation in ischemic stroke accelerates recanalization due to lower clot compaction

S. Thalerová, A. Vítečková Wünschová, P. Kittová, L. Vašátková, M. Pešková, O. Volný, A. Mac Gillavry Danylevska, J. Víteček, L. Kubala, R. Mikulík

. 2024 ; 19 (11) : e0314079. [pub] 20241119

Language English Country United States

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc25003432

Collaterals improve recanalization in acute ischemic stroke patients treated with intravenous thrombolysis, but the mechanisms are poorly understood. To investigate it, an in vitro flow model of the middle cerebral artery was developed with or without collaterals. An occlusion was achieved using human blood clots. Recanalization time, thrombolysis (clot length decrease and red blood cell (RBC) release), pressure gradient across the clot and clot compaction were measured. Results showed that with or without collateral alteplase-treated RBC dominant clots showed recanalization time 98±23 min vs 130±35 min (difference 32 min, 95% CI -6-58 min), relative clot reduction 31.8±14.9% vs 30.3±13.2% (difference 1.5%, 95% CI 10.4-13.4%) and RBC release 0.30±0.07 vs 0.27±0.09 (difference 0.03, 95% CI 0.04-0.10). Similar results were observed with fibrin-dominant clots. In RBC dominant clots, the presence vs absence of collateral caused different pressure gradients across the clot 0.41±0.09 vs 0.70±0.09 mmHg (difference 0.29 mmHg, 95% CI -0.17-0.41 mmHg), and caused the reduction of initial clot compaction by 5%. These findings align with observations in patients, where collaterals shortened recanalization time. However, collaterals did not increase thrombolysis. Instead, they decreased the pressure gradient across the clot, resulting in less clot compaction and easier distal displacement of the clot.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25003432
003      
CZ-PrNML
005      
20250206104336.0
007      
ta
008      
250121s2024 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1371/journal.pone.0314079 $2 doi
035    __
$a (PubMed)39561145
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Thalerová, Sandra $u International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic $u Department of Biophysics of Immune System, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic $u Department of Biochemistry, Faculty of Science, Masaryk University Brno, Brno, Czech Republic
245    12
$a A collateral circulation in ischemic stroke accelerates recanalization due to lower clot compaction / $c S. Thalerová, A. Vítečková Wünschová, P. Kittová, L. Vašátková, M. Pešková, O. Volný, A. Mac Gillavry Danylevska, J. Víteček, L. Kubala, R. Mikulík
520    9_
$a Collaterals improve recanalization in acute ischemic stroke patients treated with intravenous thrombolysis, but the mechanisms are poorly understood. To investigate it, an in vitro flow model of the middle cerebral artery was developed with or without collaterals. An occlusion was achieved using human blood clots. Recanalization time, thrombolysis (clot length decrease and red blood cell (RBC) release), pressure gradient across the clot and clot compaction were measured. Results showed that with or without collateral alteplase-treated RBC dominant clots showed recanalization time 98±23 min vs 130±35 min (difference 32 min, 95% CI -6-58 min), relative clot reduction 31.8±14.9% vs 30.3±13.2% (difference 1.5%, 95% CI 10.4-13.4%) and RBC release 0.30±0.07 vs 0.27±0.09 (difference 0.03, 95% CI 0.04-0.10). Similar results were observed with fibrin-dominant clots. In RBC dominant clots, the presence vs absence of collateral caused different pressure gradients across the clot 0.41±0.09 vs 0.70±0.09 mmHg (difference 0.29 mmHg, 95% CI -0.17-0.41 mmHg), and caused the reduction of initial clot compaction by 5%. These findings align with observations in patients, where collaterals shortened recanalization time. However, collaterals did not increase thrombolysis. Instead, they decreased the pressure gradient across the clot, resulting in less clot compaction and easier distal displacement of the clot.
650    _2
$a lidé $7 D006801
650    12
$a kolaterální oběh $x účinky léků $7 D003097
650    12
$a ischemická cévní mozková příhoda $x farmakoterapie $x patofyziologie $7 D000083242
650    _2
$a trombolytická terapie $x metody $7 D015912
650    _2
$a tkáňový aktivátor plazminogenu $x terapeutické užití $x farmakologie $7 D010959
650    _2
$a fibrinolytika $x terapeutické užití $x farmakologie $7 D005343
650    _2
$a erytrocyty $x účinky léků $7 D004912
650    _2
$a arteria cerebri media $x účinky léků $x patofyziologie $x diagnostické zobrazování $7 D020768
650    _2
$a trombóza $x farmakoterapie $7 D013927
655    _2
$a časopisecké články $7 D016428
700    1_
$a Vítečková Wünschová, Andrea $u International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic $u Department of Anatomy, Faculty of Medicine, Masaryk University Brno, Brno, Czech Republic
700    1_
$a Kittová, Patrícia $u International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic $u Department of Biophysics of Immune System, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic $u Department of Biochemistry, Faculty of Medicine, Masaryk University Brno, Brno, Czech Republic
700    1_
$a Vašátková, Lucie $u Department of Biophysics of Immune System, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic
700    1_
$a Pešková, Michaela $u Department of Biophysics of Immune System, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic $u Department of Biochemistry, Faculty of Science, Masaryk University Brno, Brno, Czech Republic
700    1_
$a Volný, Ondřej $u International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic
700    1_
$a Mac Gillavry Danylevska, Anna $u International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic $u Department of Histology and Embryology, Faculty of Medicine, Masaryk University Brno, Brno, Czech Republic
700    1_
$a Víteček, Jan $u International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic $u Department of Biophysics of Immune System, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic $1 https://orcid.org/0000000278804813
700    1_
$a Kubala, Lukáš $u International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic $u Department of Biophysics of Immune System, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic $1 https://orcid.org/0000000277297338 $7 xx0094314
700    1_
$a Mikulík, Robert $u International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic
773    0_
$w MED00180950 $t PloS one $x 1932-6203 $g Roč. 19, č. 11 (2024), s. e0314079
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39561145 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250121 $b ABA008
991    __
$a 20250206104332 $b ABA008
999    __
$a ok $b bmc $g 2263296 $s 1239439
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 19 $c 11 $d e0314079 $e 20241119 $i 1932-6203 $m PloS one $n PLoS One $x MED00180950
LZP    __
$a Pubmed-20250121

Find record

Citation metrics

Archiving options